Mycoplasma pneumoniae Antibodies IgG, Qualitative (Serum)
The study is designed for qualitative detection of IgG class antibodies to
Mycoplasma pneumoniae — the pathogen of atypical respiratory tract infections.
Used for confirming the fact of past mycoplasma infection or formation of the body's immune response.
Prescribed for prolonged, recurring, and sluggish respiratory tract diseases.
Applied in comprehensive diagnosis of atypical pneumonias, bronchitis, and tracheobronchitis.
Allows assessment of mycoplasma's role in chronic or past infectious process.
What the test assesses:
– Presence or absence of IgG class antibodies to Mycoplasma pneumoniae.
– Past contact of the body with the pathogen.
– Late infection stage or condition after past disease.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is advisable to exclude intense physical exertion before the examination.
Medications:
– Antibacterial medication intake usually does not affect IgG antibody levels.
– Immunoglobulin and immunomodulator intake may affect the test result.
– When taking any medications, it is recommended to notify the attending physician or indicate them when submitting the test.
Recommended for testing:
– With prolonged cough, persistent bronchitis, suspected pneumonia.
– With atypical course of inflammatory lung diseases and ineffectiveness of standard therapy.
– When mycoplasma infection is suspected.
– With frequent and prolonged respiratory diseases in children and adolescents.
– Positive result (IgG detected): indicates past infection or late disease stage; may persist for a long time after recovery.
– Negative result (IgG not detected): no contact with the pathogen or early infection stage.
Important — for diagnosing acute infection, combined determination of IgM and/or PCR testing is recommended.
